2012-02-11 04:04:24 - New Pharmaceuticals market report from Global Markets Direct: "Small-Cell Lung Cancer - Pipeline Review, H1 2012"

Small-Cell Lung Cancer - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Small-Cell Lung Cancer - Pipeline Review, H1 2012', provides an overview of the Small-Cell Lung Cancer therapeutic pipeline. This report provides information on the therapeutic development for Small-Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Small-Cell Lung Cancer. 'Small-Cell Lung Cancer - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
-

www.fastmr.com/prod/330098_smallcell_lung_cancer_pipeline_review ..


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Small-Cell Lung Cancer.
* A review of the Small-Cell Lung Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Small-Cell Lung Cancer pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Small-Cell Lung Cancer.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Small-Cell Lung Cancer pipeline depth and focus of Small-Cell Lung Cancer therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Small-Cell Lung Cancer Overview
Therapeutics Development
An Overview of Pipeline Products for Small-Cell Lung Cancer
Small-Cell Lung Cancer Therapeutics under Development by Companies
Small-Cell Lung Cancer Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Small-Cell Lung Cancer Therapeutics - Products under Development by Companies
Small-Cell Lung Cancer Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Small-Cell Lung Cancer Therapeutics Development
Bristol-Myers Squibb Company
Abbott Laboratories
Amgen Inc.
Eli Lilly and Company
GlaxoSmithKline plc
Dainippon Sumitomo Pharma Co., Ltd.
ZIOPHARM Oncology, Inc.
Millennium Pharmaceuticals, Inc.
Novartis AG
Cephalon, Inc.
ImmunoGen, Inc.
Nippon Kayaku Co., Ltd.
SuperGen, Inc.
Exelixis, Inc.
Menarini Group
Celgene Corporation
Bayer AG
Alchemia Limited
Hana Biosciences, Inc.
AEterna Zentaris Inc.
ImmunoCellular Therapeutics, Ltd.
Critical Outcome Technologies Inc.
Poniard Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc.
Synta Pharmaceuticals Corp.
Simcere Pharmaceutical Group
MabVax Therapeutics, Inc.
Acceleron Pharma, Inc.
TRION Pharma GmbH
Celator Pharmaceuticals, Inc.
Ascenta Therapeutics, Inc.
Neotropix, Inc.
MolMed S.p.A.
Innogene Kalbiotech Pte Ltd.
Krankenhaus-GmbH
Polaris Group
Theradex Systems, Inc.
Small-Cell Lung Cancer - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Sotatercept - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Amrubicin Hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Topotecan - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etoposide + Cisplatin + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Picoplatin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Etoposide + Thalidomide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Camtobell + Cisplatin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etoposide + Cisplatin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Taxol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Etoposide + Pravastatin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Etoposide + Pravastatin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide + Doxorubicin + Etoposide - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=330098&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.